Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

被引：0
|
作者：
Fei Teng
Ju-Xiang Zhang
Qi-Meng Chang
Xu-Bo Wu
Wei-Guo Tang
Jian-Fa Wang
Jin-Feng Feng
Zi-Ping Zhang
Zhi-Qiu Hu
机构：
[1] Fudan University,Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital
[2] Fudan University,Institute of Fudan
[3] Shanghai Jiao Tong University,Minhang Academic Health System, Minhang Hospital
来源：
Journal of Experimental & Clinical Cancer Research | / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An amendment to this paper has been published and can be accessed via the original article.
引用
收藏
相关论文
共 50 条
  • [31] circ0125803 facilitates tumor progression by sponging miR-197-5p and upregulating E2F1 in neuroblastoma
    Tang, Jue
    Liu, Feng
    Huang, Dongmei
    Zhao, Congling
    Liang, Jianghua
    Wang, Fenghua
    Zeng, Jiahang
    Zhang, Meilan
    Zhai, Xiaohui
    Li, Le
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 233
  • [32] LncRNA IGF2-AS promotes endometriosis progression through targeting miR-370-3p/IGF2 axis and activating PI3K/AKT/mTOR signaling pathway
    Xiaoyan Jin
    Jingjing Feng
    Xiao Cheng
    Journal of Assisted Reproduction and Genetics, 2022, 39 : 2699 - 2710
  • [33] LncRNA IGF2-AS promotes endometriosis progression through targeting miR-370-3p/IGF2 axis and activating PI3K/AKT/mTOR signaling pathway
    Jin, Xiaoyan
    Feng, Jingjing
    Cheng, Xiao
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2022, 39 (12) : 2699 - 2710
  • [34] E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription
    Hao, Fengjie
    Wang, Nan
    Zhang, Yifan
    Xu, Wen
    Chen, Yongjun
    Fei, Xiaochun
    Wang, Junqing
    MOLECULAR CARCINOGENESIS, 2022, 61 (11) : 975 - 988
  • [35] LncRNA C7orf13 facilitates cell proliferation and metastasis in nasopharyngeal carcinoma via targeting miR-449c/miR-28-5p-FMNL2 axis
    Xie, Peng
    Zhang, Yujie
    Shang, Jin
    Yu, Hanxu
    Du, Mingyu
    Shu, Jian
    Wei, Qiang
    Zhu, Zeyu
    He, Xia
    PRECISION MEDICAL SCIENCES, 2024, 13 (04): : 204 - 213
  • [36] LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis
    Huang, Yuqi
    Xiang, Bo
    Liu, Yuanhua
    Wang, Yu
    Kan, Heping
    CANCER LETTERS, 2018, 437 : 56 - 66
  • [37] LncRNA NR2F2-AS1 inhibits the progression of oral squamous cell carcinoma by mediating the miR-32-5p/SEMA3A axis
    Qin, Shi-Yu
    Li, Bo
    Liu, Ji-Mu
    Lv, Qiu-Li
    Zeng, Xiang-Lin
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2024, 40 (10): : 877 - 889
  • [38] LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
    Wei, Qing
    Liu, Guoman
    Huang, Zihua
    Huang, Yanyan
    Huang, Lizheng
    Huang, Zheng
    Wu, Xianjian
    Wei, Huamei
    Pu, Jian
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1019 - 1035
  • [39] LncRNA DLGAP1-AS1 accelerates glioblastoma cell proliferation through targeting miR-515-5p/ROCK1/NFE2L1 axis and activating Wnt signaling pathway
    Wang, Zixuan
    Han, Yipeng
    Li, Qifeng
    Wang, Baocheng
    Ma, Jie
    BRAIN AND BEHAVIOR, 2021, 11 (10):
  • [40] Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway
    Wu, Yan-Hui
    Yu, Bin
    Chen, Wei-Xun
    Ai, Xi
    Zhang, Wei
    Dong, Wei
    Shao, Ya-Jie
    AGING-US, 2021, 13 (15): : 19260 - 19271
12345